Clinical Trials
"Safety and Efficacy Evaluation of a low-cost CPAP device for COVID-19 patients: A Pilot Study"
Principal Investigator: Dr Taufiq Hasan Al BannaCRO: CRO DMC(Clinical Trial center/contract research organization,Dhaka Medical College )
Application Date: 1 Mar, 2023
A Phase 2/3. Randomized. Observer-Blind. Placebo-Controlled study to evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine targeting Respiratory Syncytial Virus (RSV), in Adults >=60 Years of Age
Principal Investigator: Dr. K Zaman MBBS, MPH, PhD, FRCP Edin Principal Investigator and Senior Scientist Infectious Diseases DivisionCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 8 Feb, 2023
A Phase 3 Study to Evaluate Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Principal Investigator: Dr. Zhahirul Islam, PhD Principal Investigator (icddr,b) ARC-10 study Scientist, Laboratory Sciences and Services Division icddr,b. Phone no. +8801710957036 Email: zislam@icddrb.orgCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 6 Feb, 2023
Bioequivalence study of test product Dienogest 2 mg Tablets of Nuvista Pharma Limited, Bangladesh comparing with reference product Visanne, containing Dienogest 2 mg, tablets of Bayer Pharma, Germany in healthy adult human female subjects under fasting conditions
Principal Investigator: Dr. Nusrat MahmudCRO: M/S. Novas Clinical Research Services Ltd. (NCRSL),
Application Date: 5 Feb, 2023
Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea
Principal Investigator: Dr. Rubhana RaqibCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 1 Feb, 2023
A Multi-country, Multi-center, Open-labelled, Randomized Controlled, Extended Phase III Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sabin Strain Inactivated Poliovirus Vaccine Administered with or without Routine Infant Vaccine
Principal Investigator: Dr Wasif Ali KhanCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 16 Jan, 2023
A Phase 2, Randomized, Observer-Blind, Controlled, Age De-escalation, Dosage Escalation Study to Assess the Safety and Immunogenicity of a Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine in Healthy Young Children, Infants, and Neonates in Bangladesh
Principal Investigator: Dr K ZamanCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 29 Nov, 2022
Bioequivalence Study of Test Product Dydrogesterone 10 mg tablet of Nuvista Pharma ltd Bangladesh comparing with reference product Duphaston tablet containing Dydrogesterone 10 mg tablet of Abott healthcare products in healthy adult human female subjects under fasting conditions .
Principal Investigator: Dr. Nusrat MahmudCRO: M/S. Novas Clinical Research Services Ltd. (NCRSL),
Application Date: 27 Nov, 2022
"Ability of the probiotic Vivomixx to improve environmental enteropathy in pregnant women: a proof of concept trial in Bangladesh, Pakistan, Senegal and Zambia"
Principal Investigator: Dr S M Tafsir HasanCRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).
Application Date: 17 Nov, 2022
Stop the transmission of Leprosy –The PEP++Project" in Bangladesh
Principal Investigator: Dr Abu Sufuan Chowdhury PI, PEP++ research ProjectCRO: Leprosy Mission International
Application Date: 15 Nov, 2022
Showing 21 to 30 of 65 results
Login with Facebook
Login with Google